Stevard LLC’s GSK GSK Stock Holding History

Stevard LLC’s Portfolio GSK Stock Details GSK Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2020 Q4	–	Sell	-4,484	Closed	-$211K	–	107
2020 Q3	$211K	Buy	+4,484	New	+$225K	0.09%	155

Other funds holding GSK

Dodge & Cox San Francisco, California $182B AUM 14.68% 1-Year Est. Return

Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return

Capital International Investors Los Angeles, California $427B AUM 29.17% 1-Year Est. Return

T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Fisher Asset Management Camas, Washington $295B AUM 31.6% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return

Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return

Hotchkis & Wiley Capital Management Los Angeles, California $32.4B AUM 17.21% 1-Year Est. Return

State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

BCIM

Black Creek Investment Management Toronto, Ontario, Canada $1.86B AUM 15.33% 1-Year Est. Return

Stevard LLC's GSK Position: Q4 2020 in Review

Stevard LLC sold out of GSK (GSK) in Q4 2020, closing a stake of 4,484 shares — an estimated $211K sold.

Stevard LLC first reported a position in GSK in Q3 2020 and held it in 1 quarter. The position peaked at $211K in Q3 2020. 818 funds tracked by Wall St. Rank hold GSK as of Q4 2020.

Stevard LLC reported no remaining GSK position as of Q4 2020 after selling out during the quarter.
Stevard LLC sold 4,484 GSK shares in Q4 2020, an estimated $211K.
Stevard LLC first reported a position in GSK in Q3 2020 and held it in 1 quarter.
Stevard LLC's GSK position peaked at $211K in Q3 2020.
818 funds tracked by Wall St. Rank held GSK as of Q4 2020.

Based on Stevard LLC's 13F filing for Q4 2020, filed 12 Feb 2021.